OLD National Bancorp IN increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 12.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 342,522 shares of the company's stock after purchasing an additional 38,060 shares during the quarter. OLD National Bancorp IN owned 0.16% of Bath & Body Works worth $10,385,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in the business. Golden State Wealth Management LLC purchased a new position in shares of Bath & Body Works in the fourth quarter worth about $26,000. SRS Capital Advisors Inc. increased its stake in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after purchasing an additional 329 shares during the period. Lindbrook Capital LLC increased its stake in Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after purchasing an additional 431 shares during the period. Smartleaf Asset Management LLC lifted its position in Bath & Body Works by 135.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after purchasing an additional 582 shares during the last quarter. Finally, UMB Bank n.a. boosted its stake in shares of Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares during the period. 95.14% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on BBWI. Barclays dropped their price target on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a research report on Friday, May 30th. Raymond James cut their target price on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research note on Thursday, April 17th. UBS Group boosted their price target on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a report on Tuesday, May 20th. The Goldman Sachs Group dropped their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. Finally, Robert W. Baird upped their target price on Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a report on Friday, February 28th. Four investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $42.00.
View Our Latest Stock Analysis on Bath & Body Works
Bath & Body Works Price Performance
NYSE:BBWI traded down $0.38 during mid-day trading on Wednesday, hitting $26.27. 4,100,485 shares of the company's stock were exchanged, compared to its average volume of 5,008,138. The company has a market cap of $5.56 billion, a PE ratio of 6.41, a P/E/G ratio of 0.92 and a beta of 1.72. Bath & Body Works, Inc. has a one year low of $24.96 and a one year high of $45.99. The business has a fifty day moving average price of $29.52 and a 200 day moving average price of $33.75.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.40 billion for the quarter, compared to analysts' expectations of $1.42 billion. During the same period in the previous year, the firm posted $0.38 EPS. The business's revenue for the quarter was up 2.9% compared to the same quarter last year. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, June 6th. This represents a $0.80 annualized dividend and a dividend yield of 3.05%. Bath & Body Works's payout ratio is presently 21.33%.
Bath & Body Works declared that its board has initiated a stock repurchase program on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's board of directors believes its shares are undervalued.
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Further Reading

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.